Mp59-13 Long-Term Testosterone Therapy in Men With Functional Hypogonadism Is Associated With Improved Lower Urinary Tract Symptoms and Quality of Life

You have accessJournal of UrologyUrodynamics/Lower Urinary Tract Dysfunction/Female Pelvic Medicine: Basic Research -12.6] (p<0.0001). RBV in the T-group (baseline: 55.5±24.1) decreased to 10.4±1.8 mL (p<0.0001) in year 15. In CTRL, RBV (baseline: 52.5±18.4) increased to 106.0±37.7 mL (p<0.0001). The estimated adjusted difference between groups was -106.8 mL 95% CI: -112.0;-101.7 (p<0.0001).QoL, assessed by the Aging Males' Symptoms scale (AMS), improved from 53.8±9.8 (severe symptoms) to 17.3±0.5 (no symptoms) in the T-group and worsened from 40.7±5.8 (moderate symptoms) to 67.0±5.9 (severe symptoms) in CTRL. The estimated adjusted difference between groups at 15 years was -55.2 95% CI: -56.7;-53.8 (p<0.0001 for all). CONCLUSIONS: In men with functional hypogonadism, long-term TTh is associated with sustainably improved LUTS over 15 years. This may have contributed to improvements in QoL. In the untreated control group, LUTS and QoL deteriorated. Source of Funding: Data entry was funded by Bayer AG © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 211Issue 5SMay 2024Page: e962 Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.Metrics Author Information Karim Sultan Haider More articles by this author Ahmad Haider More articles by this author Gheorghe Doros More articles by this author Abdulmaged Traish More articles by this author Expand All Advertisement PDF downloadLoading ...